Role of sentinel lymph node biopsy as a staging procedure in patients with melanoma: A critical appraisal.

about

Role of sentinel lymph node biopsy as a staging procedure in patients with melanoma: A critical appraisal.

Item

http://www.wikidata.org/entity/Q39434556

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Role of sentinel lymph node bi ...... elanoma: A critical appraisal.

@en

Role of sentinel lymph node bi ...... elanoma: A critical appraisal.

@nl

type

Item

label

Role of sentinel lymph node bi ...... elanoma: A critical appraisal.

@en

Role of sentinel lymph node bi ...... elanoma: A critical appraisal.

@nl

prefLabel

Role of sentinel lymph node bi ...... elanoma: A critical appraisal.

@en

Role of sentinel lymph node bi ...... elanoma: A critical appraisal.

@nl

P1476

Role of sentinel lymph node bi ...... melanoma: A critical appraisal

@en

P2093

Alan Cooper

http://www.w3.org/2001/XMLSchema#string

John F Thompson

http://www.w3.org/2001/XMLSchema#string

P2860

Sentinel-lymph-node biopsy for cutaneous melanoma

Final trial report of sentinel-node biopsy versus nodal observation in melanoma.

Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system.

Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma.

The impact on morbidity and length of stay of early versus delayed complete lymphadenectomy in melanoma: results of the Multicenter Selective Lymphadenectomy Trial (I).

Sentinel-node biopsy or nodal observation in melanoma.

False negative sentinel lymph node biopsies in melanoma may result from deficiencies in nuclear medicine, surgery, or pathology.

The detection and significance of melanoma micrometastases in sentinel nodes.

Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial.

Latent subgroup analysis of a randomized clinical trial through a semiparametric accelerated failure time mixture model.

P304

268-273

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/AJD.12655

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Omgo E Nieweg

P577

2017-07-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28707391

http://www.w3.org/2001/XMLSchema#string

P921

lymph node

biopsy